TA-650 (Infliximab)
Drug timelines are a Plus or Pro feature.
2 regulatory and trial events tracked for TA-650 (Infliximab), covering 2012-12-05 to 2013-05-20. Get the full timeline:
Most recent: Clinical Trial Update: Efficacy and Safety of Increased Dose of TA-650(Infliximab) in Patients With Rheumatoid Arthritis [Phase 3]